Euroapi SA

Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline

03 Mar 2025 12:35:21 By Nasdaq GlobeNewswire

EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannick Neuder and the French Minister for Industry and Energy Marc Ferracci to its Puy-de-Dôme site

06 Jan 2025 11:40:31 By Nasdaq GlobeNewswire

EUROAPI moves into a new chapter with new Governance and Leadership 

09 Dec 2024 14:17:08 By Nasdaq GlobeNewswire

Olivier Falut appointed EUROAPI’s Chief Financial Officer

16 Oct 2024 01:00:00 By Nasdaq GlobeNewswire

EUROAPI closes the financing of its FOCUS-27 plan

15 Oct 2024 11:45:00 By Nasdaq GlobeNewswire

EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution

10 Oct 2024 14:38:18 By Nasdaq GlobeNewswire

H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap

30 Jul 2024 11:45:00 By Nasdaq GlobeNewswire

EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1

26 Jun 2024 11:40:00 By Nasdaq GlobeNewswire

EUROAPI and Priothera enter into CDMO collaboration to advance oncology project

18 Jun 2024 01:00:00 By Nasdaq GlobeNewswire

Market update : FOCUS-27 transformation project financing

06 Jun 2024 11:53:58 By Nasdaq GlobeNewswire

EUROAPI reaches major Health IPCEI milestone with official notification from European Commission

06 Jun 2024 01:00:00 By Nasdaq GlobeNewswire

EUROAPI strengthens its presence in animal health with a €130-150 million supply contract

23 May 2024 01:00:00 By Nasdaq GlobeNewswire

Combined General Meeting of May 22, 2024

22 May 2024 11:45:00 By Nasdaq GlobeNewswire

Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer

13 May 2024 12:00:00 By Nasdaq GlobeNewswire

Combined General Meeting of May 22, 2024 - Availability of preparatory documents

30 Apr 2024 01:00:00 By Nasdaq GlobeNewswire

EUROAPI streamlines its Executive Committee to improve focus and efficiency

09 Apr 2024 12:18:36 By Nasdaq GlobeNewswire

Availability of the 2023 Universal Registration Document, including the Annual Financial Report

05 Apr 2024 12:21:17 By Nasdaq GlobeNewswire

2023 Universal Registration Document

28 Mar 2024 02:00:00 By Nasdaq GlobeNewswire

Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy

14 Mar 2024 13:55:26 By Nasdaq GlobeNewswire

Full-year 2023 results

28 Feb 2024 13:16:50 By Nasdaq GlobeNewswire